Table 5.

OR (95% CI) for association of serum GST-α concentrations and prostate cancer in the EPIC-Heidelberg nested case-control study (n = 715)

GST-αCases/controlsCrude* OR (95% CI)Adjusted OR (95% CI)Adjusted OR (95% CI)
1st tertile (<2.17 μg/L)106/1571.001.001.00
2nd tertile (2.18-3.72 μg/L)81/1570.79 (0.55-1.14)0.78 (0.54-1.12)0.77 (0.53-1.11)
3rd tertile (≥3.73 μg/L)56/1580.54 (0.37-0.80)0.53 (0.36-0.80)0.53 (0.35-0.80)
Continuous§0.77 (0.66-0.91)0.77 (0.65-0.91)0.75 (0.63-0.90)
  • *Conditional logistic regression stratified by case set.

  • Additionally adjusted for BMI and alcohol intake.

  • Additionally adjusted for glucosinolate intake.

  • §Per unit increment of log-transformed GST-α.